1-(1,3-Dimethyl-1 H -pyrazol-4-ylmethyl)-1 H -pyrazol-4-ylamine, 97%, 1g

N-Hydroxysuccinimide, min. 99%, for synthesis, 25 g, glass packaging

[2-(4-chlorophenyl)-2-(1-piperidinyl)ethyl]amine, 95.0%, 1g

(2S)-tert-Butyl 3-cyano-2-methyl-4-oxopiperidine-1-carboxylate, 97%, 1g

2-(3,5-Dibromophenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 95+%, 10g

TERT-BUTYL 3-(FLUOROMETHYL)AZETIDINE-1-CARBOXYLATE, 95.0%, 5g

Citraconic Acid>98.0%(GC)(T)500g

6-bromo-8-methoxy-1,2,3,4-tetrahydro-1,5-naphthyridine, 95.0%, 250mg

3-(4-Acetamidophenyl)propanoic acid, 95%, 500mg

Piperidine-1,3-dicarboxylic acid 1-benzyl ester 3-methyl ester, 95.0%, 25g

5-(2-Bromo-4-nitro-phenyl)-furan-2-carbaldehyde, 250mg

2,3-Dimethylpyrido[3,4-b]pyrazin-5(6H)-one, 97.0%, 100mg

5-Oxononanoic acid, 97.0%, 250mg